Success Metrics

Clinical Success Rate
95.5%

Based on 64 completed trials

Completion Rate
96%(64/67)
Active Trials
8(8%)
Results Posted
17%(11 trials)
Terminated
3(3%)

Phase Distribution

Ph not_applicable
50
52%
Ph phase_3
7
7%
Ph early_phase_1
3
3%
Ph phase_4
16
17%
Ph phase_1
5
5%
Ph phase_2
15
16%

Phase Distribution

8

Early Stage

15

Mid Stage

23

Late Stage

Phase Distribution96 total trials
Early Phase 1First-in-human
3(3.1%)
Phase 1Safety & dosage
5(5.2%)
Phase 2Efficacy & side effects
15(15.6%)
Phase 3Large-scale testing
7(7.3%)
Phase 4Post-market surveillance
16(16.7%)
N/ANon-phased studies
50(52.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

95.5%

64 of 67 finished

Non-Completion Rate

4.5%

3 ended early

Currently Active

8

trials recruiting

Total Trials

96

all time

Status Distribution
Active(11)
Completed(64)
Terminated(3)
Other(18)

Detailed Status

Completed64
unknown18
Active, not recruiting4
Recruiting4
Terminated3
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
96
Active
8
Success Rate
95.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (3.1%)
Phase 15 (5.2%)
Phase 215 (15.6%)
Phase 37 (7.3%)
Phase 416 (16.7%)
N/A50 (52.1%)

Trials by Status

terminated33%
unknown1819%
not_yet_recruiting22%
active_not_recruiting44%
completed6467%
recruiting44%
enrolling_by_invitation11%

Recent Activity

Clinical Trials (96)

Showing 20 of 96 trialsScroll for more
NCT07031388Not Applicable

Mouthwashes for Gingivitis: Comparing a Hydrogen Peroxide-Hyaluronic Acid Mix, Hyaluronic Acid, and Chlorhexidine, A Triple-Blind Clinical Trial

Completed
NCT06120140Phase 2

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

Active Not Recruiting
NCT03977298Not Applicable

Surgical Protocol for Peri-Implantitis Treatment-4

Completed
NCT07833176Not Applicable

Comparative Efficacy of Amoxicillin, Metronidazole, and Chlorhexidine in Preventing Alveolar Osteitis

Not Yet Recruiting
NCT06627270Phase 2

Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer

Recruiting
NCT07742826Not Applicable

Comparison of PRF and Corticosteroids in Impacted Third Molar Surgery

Recruiting
NCT06489431Phase 3

Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement

Active Not Recruiting
NCT05024760Early Phase 1

Antiseptic Effects on the Dental Implant Internal Surface Microbiome

Completed
NCT03484507Phase 2

Parasitic Ulcer Treatment Trial Pilot

Completed
NCT04171817Phase 4

Animal-Assisted Visitation Program Chlorhexidine Trial

Completed
NCT07058727Not Applicable

Different Hemostatic Agents Used in Partial Pulpotomy on Pulp Survival and Postoperative Pain

Recruiting
NCT02572791Phase 4

Staph Household Intervention for Eradication (SHINE)

Completed
NCT06598514Phase 4

Chlorhexidine Lavage for Recurrent Urinary Tract Infection

Active Not Recruiting
NCT07270952Phase 4

Protocol Efficacy of Mouthwashes in Experimental Gingivitis

Completed
NCT07197073Not Applicable

Antibacterial Effect of Ozonated Olive Oil, Propolis and Chlorhexidine Mouthwashes in Pediatric Patients

Completed
NCT07048899Phase 4

Irrisept in Emergency General Surgery Patients

Enrolling By Invitation
NCT07001527Phase 3

Dressing Impregnated With Chlorhexidine and Vancomycin for the Prophylaxis of Central Venous Catheter-related Infections - a Randomized Trial

Completed
NCT05913856Not Applicable

The Effectiveness of Oral Care With Chlorhexidine in Medical Intensive Care Unit

Completed
NCT06667089Not Applicable

Povidone-Iodine Versus Chlorhexidine in Surgical Wound Care

Completed
NCT06834711Not Applicable

Chlorhexidine Versus N-Asetil Sistein Irrigation in Mandibular Molar Teeth with Chronic Apical Periodontitis

Completed

Drug Details

Intervention Type
COMBINATION PRODUCT
Total Trials
96